Viewing Study NCT03404960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-01-25 @ 11:59 PM
Study NCT ID: NCT03404960
Status: COMPLETED
Last Update Posted: 2025-10-10
First Post: 2017-12-19
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based Chemotherapy
Sponsor: University of Pennsylvania
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Adenocarcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Platinum View
None chemotherapy View
None Niraparib View
None Ipilimumab View
None Nivolumab View
None Pancreatic adenocarcinoma View
None PARP inhibitor View
None Pancreatic ductal adenocarcinoma View
None DDR View
None PDAC View